↓ Skip to main content

Combating poor-quality anti-malarial medicines: a call to action

Overview of attention for article published in Malaria Journal, June 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
22 X users
facebook
2 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
144 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combating poor-quality anti-malarial medicines: a call to action
Published in
Malaria Journal, June 2016
DOI 10.1186/s12936-016-1357-8
Pubmed ID
Authors

Quique Bassat, Marcel Tanner, Philippe J. Guerin, Kirstin Stricker, Kamal Hamed

Abstract

The circulation of poor-quality medicines continues to undermine the fight against many life-threatening diseases. Anti-malarial medicines appear to have been particularly compromised and present a major public health threat in malaria-endemic countries, negatively affecting individuals and their communities. Concerted collaborative efforts are required from global, regional and national organizations, involving the public and private sectors, to address the problem. While many initiatives are underway, a number of unmet needs deserve urgent and increased multisector attention. At the global level, there is a need for an international public health legal framework or treaty on poor-quality medicines, with statutes suitable for integration into national laws. In addition, increased international efforts are required to strengthen the governance of global supply chains and enhance cooperation between national medicine regulation authorities and law enforcement bodies. Increased investment is needed in innovative technologies that will enable healthcare teams to detect poor-quality medicines at all levels of the supply chain. At the regional level, a number of initiatives would be beneficial-key areas are standardization, simplification, and reciprocal recognition of registration processes and development of quality control capacity in regional centres of excellence that are better aligned with public health needs; improved surveillance methods and creation of a framework for compulsory and transparent reporting of poor-quality medicines; additional support for national medicine regulation authorities and other national partner authorities; and an increase in support for regional laboratories to boost their capabilities in detecting poor-quality medicines. It is vital that all stakeholders involved in efforts against poor-quality anti-malarial medicines extend and strengthen their actions in these critical areas and thus effectively support global health development and malaria elimination programmes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 <1%
Spain 1 <1%
Unknown 142 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 18%
Student > Ph. D. Student 16 11%
Researcher 12 8%
Student > Bachelor 12 8%
Student > Doctoral Student 9 6%
Other 24 17%
Unknown 45 31%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 27 19%
Medicine and Dentistry 19 13%
Business, Management and Accounting 9 6%
Nursing and Health Professions 8 6%
Agricultural and Biological Sciences 7 5%
Other 27 19%
Unknown 47 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2020.
All research outputs
#2,200,420
of 24,004,724 outputs
Outputs from Malaria Journal
#438
of 5,767 outputs
Outputs of similar age
#39,523
of 343,930 outputs
Outputs of similar age from Malaria Journal
#8
of 147 outputs
Altmetric has tracked 24,004,724 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,767 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,930 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 147 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.